Activities of triazole-echinocandin combinations against Candida species in biofilms and as planktonic cells

Athanasios Chatzimoschou, Aspasia Katragkou, Maria Simitsopoulou, Charalampos Antachopoulos, Elpiniki Georgiadou, Thomas J. Walsh, Emmanuel Roilides

Research output: Contribution to journalArticle

Abstract

Biofilm formation complicates the treatment of various infections caused by Candida species. We investigated the effects of simultaneous or sequential combinations of two triazoles, voriconazole (VRC) and posaconazole (PSC), with two echinocandins, anidulafungin (AND) and caspofungin (CAS), against Candida albicans and Candida parapsilosis biofilms in comparison to their planktonic counterparts. Anti-fungal activity was assessed by the 2,3-bis[2-methoxy-4- nitro-5-sulfophenyl]2H-tetrazolium-5-carboxanilide (XTT) metabolic assay. Antifungal-agent interactions were analyzed by the Bliss independence model in the simultaneous-treatment studies and by analysis of variance (ANOVA) in the sequential-treatment studies. Against C. albicans planktonic cells, the simultaneous combination of PSC (32 to 128 mg/liter) and CAS (0.008 to 0.25 mg/liter) was synergistic; the combinations of PSC (128 to 1,024 mg/liter) with AND (0.03 to 0.5 mg/liter) and VRC (32 to 512 mg/liter) with AND (0.008 to 0.03 mg/liter) were antagonistic. Against C. parapsilosis planktonic cells, the interaction between VRC (32 to 1,024 mg/liter) and CAS (1 to 16 mg/liter) was antagonistic. All simultaneous antifungal combinations demonstrated indifferent interactions against biofilms of both Candida species. Damage to biofilms of both species increased (P <0.01) in the presence of subinhibitory concentrations of echinocandins (0.008 to 0.064 mg/liter), followed by the addition of PSC (512 mg/liter for C. albicans and 64 to 512 mg/liter for C. parapsilosis) or VRC (256 to 512 mg/liter for C. albicans and 512 mg/liter for C. parapsilosis). Triazole-echinocandin combinations do not appear to produce antagonistic effects against Candida sp. biofilms, while various significant interactions occur with their planktonic counterparts.

Original languageEnglish (US)
Pages (from-to)1968-1974
Number of pages7
JournalAntimicrobial Agents and Chemotherapy
Volume55
Issue number5
DOIs
StatePublished - May 2011
Externally publishedYes

Fingerprint

Echinocandins
caspofungin
Triazoles
anidulafungin
Biofilms
Candida
Candida albicans
Antifungal Agents
Cell Communication
Analysis of Variance
posaconazole
Voriconazole
Infection

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology
  • Infectious Diseases

Cite this

Chatzimoschou, A., Katragkou, A., Simitsopoulou, M., Antachopoulos, C., Georgiadou, E., Walsh, T. J., & Roilides, E. (2011). Activities of triazole-echinocandin combinations against Candida species in biofilms and as planktonic cells. Antimicrobial Agents and Chemotherapy, 55(5), 1968-1974. https://doi.org/10.1128/AAC.00959-10

Activities of triazole-echinocandin combinations against Candida species in biofilms and as planktonic cells. / Chatzimoschou, Athanasios; Katragkou, Aspasia; Simitsopoulou, Maria; Antachopoulos, Charalampos; Georgiadou, Elpiniki; Walsh, Thomas J.; Roilides, Emmanuel.

In: Antimicrobial Agents and Chemotherapy, Vol. 55, No. 5, 05.2011, p. 1968-1974.

Research output: Contribution to journalArticle

Chatzimoschou, A, Katragkou, A, Simitsopoulou, M, Antachopoulos, C, Georgiadou, E, Walsh, TJ & Roilides, E 2011, 'Activities of triazole-echinocandin combinations against Candida species in biofilms and as planktonic cells', Antimicrobial Agents and Chemotherapy, vol. 55, no. 5, pp. 1968-1974. https://doi.org/10.1128/AAC.00959-10
Chatzimoschou A, Katragkou A, Simitsopoulou M, Antachopoulos C, Georgiadou E, Walsh TJ et al. Activities of triazole-echinocandin combinations against Candida species in biofilms and as planktonic cells. Antimicrobial Agents and Chemotherapy. 2011 May;55(5):1968-1974. https://doi.org/10.1128/AAC.00959-10
Chatzimoschou, Athanasios ; Katragkou, Aspasia ; Simitsopoulou, Maria ; Antachopoulos, Charalampos ; Georgiadou, Elpiniki ; Walsh, Thomas J. ; Roilides, Emmanuel. / Activities of triazole-echinocandin combinations against Candida species in biofilms and as planktonic cells. In: Antimicrobial Agents and Chemotherapy. 2011 ; Vol. 55, No. 5. pp. 1968-1974.
@article{59bdf18fc855428c97ccfb23aa751ca2,
title = "Activities of triazole-echinocandin combinations against Candida species in biofilms and as planktonic cells",
abstract = "Biofilm formation complicates the treatment of various infections caused by Candida species. We investigated the effects of simultaneous or sequential combinations of two triazoles, voriconazole (VRC) and posaconazole (PSC), with two echinocandins, anidulafungin (AND) and caspofungin (CAS), against Candida albicans and Candida parapsilosis biofilms in comparison to their planktonic counterparts. Anti-fungal activity was assessed by the 2,3-bis[2-methoxy-4- nitro-5-sulfophenyl]2H-tetrazolium-5-carboxanilide (XTT) metabolic assay. Antifungal-agent interactions were analyzed by the Bliss independence model in the simultaneous-treatment studies and by analysis of variance (ANOVA) in the sequential-treatment studies. Against C. albicans planktonic cells, the simultaneous combination of PSC (32 to 128 mg/liter) and CAS (0.008 to 0.25 mg/liter) was synergistic; the combinations of PSC (128 to 1,024 mg/liter) with AND (0.03 to 0.5 mg/liter) and VRC (32 to 512 mg/liter) with AND (0.008 to 0.03 mg/liter) were antagonistic. Against C. parapsilosis planktonic cells, the interaction between VRC (32 to 1,024 mg/liter) and CAS (1 to 16 mg/liter) was antagonistic. All simultaneous antifungal combinations demonstrated indifferent interactions against biofilms of both Candida species. Damage to biofilms of both species increased (P <0.01) in the presence of subinhibitory concentrations of echinocandins (0.008 to 0.064 mg/liter), followed by the addition of PSC (512 mg/liter for C. albicans and 64 to 512 mg/liter for C. parapsilosis) or VRC (256 to 512 mg/liter for C. albicans and 512 mg/liter for C. parapsilosis). Triazole-echinocandin combinations do not appear to produce antagonistic effects against Candida sp. biofilms, while various significant interactions occur with their planktonic counterparts.",
author = "Athanasios Chatzimoschou and Aspasia Katragkou and Maria Simitsopoulou and Charalampos Antachopoulos and Elpiniki Georgiadou and Walsh, {Thomas J.} and Emmanuel Roilides",
year = "2011",
month = "5",
doi = "10.1128/AAC.00959-10",
language = "English (US)",
volume = "55",
pages = "1968--1974",
journal = "Antimicrobial Agents and Chemotherapy",
issn = "0066-4804",
publisher = "American Society for Microbiology",
number = "5",

}

TY - JOUR

T1 - Activities of triazole-echinocandin combinations against Candida species in biofilms and as planktonic cells

AU - Chatzimoschou, Athanasios

AU - Katragkou, Aspasia

AU - Simitsopoulou, Maria

AU - Antachopoulos, Charalampos

AU - Georgiadou, Elpiniki

AU - Walsh, Thomas J.

AU - Roilides, Emmanuel

PY - 2011/5

Y1 - 2011/5

N2 - Biofilm formation complicates the treatment of various infections caused by Candida species. We investigated the effects of simultaneous or sequential combinations of two triazoles, voriconazole (VRC) and posaconazole (PSC), with two echinocandins, anidulafungin (AND) and caspofungin (CAS), against Candida albicans and Candida parapsilosis biofilms in comparison to their planktonic counterparts. Anti-fungal activity was assessed by the 2,3-bis[2-methoxy-4- nitro-5-sulfophenyl]2H-tetrazolium-5-carboxanilide (XTT) metabolic assay. Antifungal-agent interactions were analyzed by the Bliss independence model in the simultaneous-treatment studies and by analysis of variance (ANOVA) in the sequential-treatment studies. Against C. albicans planktonic cells, the simultaneous combination of PSC (32 to 128 mg/liter) and CAS (0.008 to 0.25 mg/liter) was synergistic; the combinations of PSC (128 to 1,024 mg/liter) with AND (0.03 to 0.5 mg/liter) and VRC (32 to 512 mg/liter) with AND (0.008 to 0.03 mg/liter) were antagonistic. Against C. parapsilosis planktonic cells, the interaction between VRC (32 to 1,024 mg/liter) and CAS (1 to 16 mg/liter) was antagonistic. All simultaneous antifungal combinations demonstrated indifferent interactions against biofilms of both Candida species. Damage to biofilms of both species increased (P <0.01) in the presence of subinhibitory concentrations of echinocandins (0.008 to 0.064 mg/liter), followed by the addition of PSC (512 mg/liter for C. albicans and 64 to 512 mg/liter for C. parapsilosis) or VRC (256 to 512 mg/liter for C. albicans and 512 mg/liter for C. parapsilosis). Triazole-echinocandin combinations do not appear to produce antagonistic effects against Candida sp. biofilms, while various significant interactions occur with their planktonic counterparts.

AB - Biofilm formation complicates the treatment of various infections caused by Candida species. We investigated the effects of simultaneous or sequential combinations of two triazoles, voriconazole (VRC) and posaconazole (PSC), with two echinocandins, anidulafungin (AND) and caspofungin (CAS), against Candida albicans and Candida parapsilosis biofilms in comparison to their planktonic counterparts. Anti-fungal activity was assessed by the 2,3-bis[2-methoxy-4- nitro-5-sulfophenyl]2H-tetrazolium-5-carboxanilide (XTT) metabolic assay. Antifungal-agent interactions were analyzed by the Bliss independence model in the simultaneous-treatment studies and by analysis of variance (ANOVA) in the sequential-treatment studies. Against C. albicans planktonic cells, the simultaneous combination of PSC (32 to 128 mg/liter) and CAS (0.008 to 0.25 mg/liter) was synergistic; the combinations of PSC (128 to 1,024 mg/liter) with AND (0.03 to 0.5 mg/liter) and VRC (32 to 512 mg/liter) with AND (0.008 to 0.03 mg/liter) were antagonistic. Against C. parapsilosis planktonic cells, the interaction between VRC (32 to 1,024 mg/liter) and CAS (1 to 16 mg/liter) was antagonistic. All simultaneous antifungal combinations demonstrated indifferent interactions against biofilms of both Candida species. Damage to biofilms of both species increased (P <0.01) in the presence of subinhibitory concentrations of echinocandins (0.008 to 0.064 mg/liter), followed by the addition of PSC (512 mg/liter for C. albicans and 64 to 512 mg/liter for C. parapsilosis) or VRC (256 to 512 mg/liter for C. albicans and 512 mg/liter for C. parapsilosis). Triazole-echinocandin combinations do not appear to produce antagonistic effects against Candida sp. biofilms, while various significant interactions occur with their planktonic counterparts.

UR - http://www.scopus.com/inward/record.url?scp=79955545195&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955545195&partnerID=8YFLogxK

U2 - 10.1128/AAC.00959-10

DO - 10.1128/AAC.00959-10

M3 - Article

VL - 55

SP - 1968

EP - 1974

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

SN - 0066-4804

IS - 5

ER -